Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ELCC 2017 | Molecular tools for lung cancer therapies

Charles Swanton, FRCP, BSc, PhD from the Francis Crick Institute, London, UK discusses the up and coming molecular tools in lung cancer. A subset of patients are at higher risk of disease recurrence after receiving first-line therapy, and it is crucial to develop successful second-line therapies for these patients. This interview was recorded at the annual meeting of the European Lung Cancer Conference (ELCC) 2017, Geneva, Switzerland.